Tigermed Reports 2022 Interim Result with Strong Financial Growth
- Written by PR Newswire
HANGZHOU, China, Aug. 25, 2022 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its interim results for the first half of 2022, ended June 30,...
Read more: Tigermed Reports 2022 Interim Result with Strong Financial Growth














